Serri O, Somma M, Beauregard H, Rasio E, Comtois R, Aris-Jilwan N, Boucher A, Hardy J
Service d'endocrinologie, hôpital Notre-Dame, Université de Montréal, Québec.
Union Med Can. 1993 Nov-Dec;122(6):496-9.
Prolactinoma is the most common type of secretory pituitary tumor. The clinical presentation varies with age and sex, and the size of the adenoma. The differential diagnosis with nonfunctioning adenoma and hyperprolactinemia is particularly important in selecting an appropriate therapy. The choice of therapy depends on a number of factors including the patient's preference. In cases of radiologically undetectable microprolactinomas, we prefer observation only. However, hypogonadic patients are treated with bromocriptine. Generally, it is our recommendation that almost all of the patients with micro--and macroprolactinomas undergo a primary medical therapy, provided they are willing to continue such therapy on a long term basis. We recommend transsphenoidal surgery for patients who refuse long term medical therapy and in rare cases of prolactinomas which are unresponsive to medical therapy. We also consider surgery as a valuable alternative to medical therapy in patients with microprolactinomas and prolactin below 200 micrograms/L.
催乳素瘤是最常见的分泌性垂体瘤类型。其临床表现因年龄、性别以及腺瘤大小而异。在选择合适的治疗方法时,与无功能腺瘤和高催乳素血症进行鉴别诊断尤为重要。治疗方法的选择取决于多种因素,包括患者的偏好。对于影像学检查无法发现的微催乳素瘤病例,我们仅倾向于观察。然而,性腺功能减退的患者则用溴隐亭治疗。一般来说,我们建议几乎所有微腺瘤和大腺瘤患者接受初始药物治疗,前提是他们愿意长期持续这种治疗。对于拒绝长期药物治疗的患者以及极少数对药物治疗无反应的催乳素瘤患者,我们建议行经蝶窦手术。对于微催乳素瘤且催乳素水平低于200微克/升的患者,我们也认为手术是药物治疗的一种有价值的替代方法。